Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Polycystic Ovary Syndrome 2Peripheral Nervous System Diseases 2Neurofibromatosis 1 2Lung Neoplasms 2Liver Neoplasms 2Weight Loss 1Tongue Neoplasms 1Stomatitis 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Renal Insufficiency, Chronic 1Renal Artery Obstruction 1Radiation-Induced Mucositis 1Pulmonary Embolism 1Primary Graft Dysfunction 1Ototoxicity 1Osteosarcoma 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Myofibroma 1Muscular Atrophy 1Mucositis 1Melanoma 1Lymphoma, Non-Hodgkin 1Liver Failure, Acute 1Liver Failure 1Liver Diseases 1Insulin Resistance 1Inflammation 1

Interventions

Dalteparin 7apixaban 6Rivaroxaban 3edoxaban 2bemiparin 2Warfarin 2Tinzaparin 2Fondaparinux 2Enoxaparin 2Dabigatran 2Phenprocoumon 1Nephrectomy 1Nadroparin 1Heparin, Low-Molecular-Weight 1Heparin 1Aspirin 1Acetylcysteine 1Acenocoumarol 14-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pulmonary Embolism × Acetylcysteine × Clear all
NCT02476526 2017-11-28

Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease

VA Greater Los Angeles Healthcare System

Phase 4 Completed
50 enrolled
Thoracic

Lung Neoplasms, Pulmonary Embolism, Renal Artery Obstruction, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡